IISPV Competitors

U.N.A.M. Facultad de Artes y Diseño: Plantel Xochimilco. Plantel Academia de San Carlos. Plantel Taxco. Plantel Unidad de Posgrado Centro Cultural Universitario. Licenciaturas: Licenciatura en Artes Visuales. Licenciatura en Diseño y Comunicación Visual. Licenciatura en Artes y Diseño. Maestría en Artes Visuales. Maestría en Diseño y Comunicación Visual. Maestría en Docencia en Artes y Diseño. Maestría en Cine Documental. Doctorado en Artes y Diseño.

The University of Barcelona (UB) is Spain’s leading research university, publishing more research than any other Spanish institution with the exception of the Spanish National Research Council (CSIC). The UB has 106 departments and more than 5,000 full-time researchers, technicians and research assistants, most of whom work in the UB’s 243 research groups as recognized and supported by the Generalitat de Catalunya. In 2010 the UB was awarded 175 national research grants and 17 European grants and participated in over 500 joint research projects with the business sector, generating an overall research income of 70 million euros. The work of these groups is overseen by the UB’s research centres and institutes which collaborate with the leading research institutions and networks in Spain and abroad. The UB is also home to three large research foundations: the Barcelona Science Park Foundation (PCB), which includes the Institute of Biomedical Research (IRBB); the August Pi i Sunyer Biomedical Research Institute (IDIBAPS); and the Bellvitge Institute for Biomedical Research (IDIBELL). The guidelines for research policy are drawn up by the Office of the Vice-Rector for Research. Research activities are managed by the UB office Research Management (OGR), which is in charge of national research programs, the UB office European Research Projects (OPER), which is responsible for European projects, and the Bosch i Gimpera Foundation (FBG),

Under the leadership of Josep Tabernero, the Vall d’Hebron Institute of Oncology (VHIO) has established itself as a cancer research center of proven excellence internationally. It is thanks to Josep's directorship and VHIO's optimal organizational structure based on a purely multidisciplinary and translational model that VHIO talents continue to anticipate and tackle the many unresolved questions in combatting this multifaceted and heterogeneous disease. Located within the Vall d´Hebron Barcelona Hospital Campus, our researchers closely collaborate and interact with Vall d´Hebron University Hospital physician-scientists. Translational science and clinical research are therefore tightly connected which promotes superb interaction and teamwork which, in turn, accelerates the bench-bedside-bed cycle of knowledge. This privileged environment affords VHIO direct access to patients as well as the entire spectrum of oncology professionals who care for them, and a second-to-none appreciation of how cancer science can translate into more powerful, targeted treatments and better practice for the care of patients. VHIO's pioneering model and programs, coupled with its belief in combining strengths through cross-border collaborations, continue to spur advances in reversing cancer resistance, halting metastatic spread and more effectively treating even the most undruggable tumour types. VHIO's translation toward precision oncology.